Lawmakers must 'keep their options open' on Social Security reform, former Treasury Secretary Jack Lew says Analysis: Warsh rate hike reinforces Fed independence after Trump pressure Americans' incomes rose and poverty fell in 2025, Census Bureau says OpenAI CFO Sarah Friar emphasizes 'need to take safety seriously' on AI risks Elon Musk, the world’s richest man, says he’s living in an Airstream trailer to oversee xAI’s biggest expansion yet Dominant Kerr wins $150K with GB's first Ultimate title Amid war and sanctions, many Iranians are losing their jobs and struggling to get by Dan Chung rebuilt a decimated Alger Management after 9/11. He's still finding the market's winners Kenya's foreign trader crackdown sparks fear among migrant communities OpenAI says it cracked one of math’s grand challenges. But there are troubling questions about how they did it—and what it means for us all

Pablo Legorreta

Pablo Legorreta

Pablo Legorreta (#821)

Global Rank #821
Country Rank #333
Country United States

Pablo Legorreta is listed among the world billionaires tracked by Iconic Billionaires.

  • $ 5 B
  • Investments
  • United States
  • M
  • 62 Years

Snapshot

Quick Facts

Global Rank #821
Country Rank #333
Net Worth $5.2B
Previous Worth $5.2B
Worth Change +$0.0B
Country United States
Industry Investments
Age 62 Years
Gender M
Worth As Of May 4, 2026
Last Refreshed 10 Sep 2026, 12:00 AM
Residence Sag Harbor, New York
World Billionaires List United States Billionaires Investments

Profile Data

Personal Stats

Age 62
Source Of Wealth Investments, Self Made
Self Made Score 8
Philanthropy Score 1
Residence Sag Harbor, New York
Citizenship United States
Marital Status Married
Children 2
Education Bachelor of Science in Engineering, Universidad Iberoamericana
Net Worth Change +$0.0B +0.0% from previous worth
Previous Net Worth $5.2B
Current Net Worth $5.2B

Worth as of May 4, 2026

About Me

Pablo Legorreta is the founder of Royalty Pharma, the world's biggest acquirer of pharmaceutical royalty streams. Royalty Pharma, which conducted an IPO in 2020, has collected revenue slices of blockbuster drugs like Humira, Imbruvica, Lyrica, and Xtandi. A former investment banker at Lazard Fr'res, Legoretta started Royalty Pharma in New York as a private equity vehicle in 1996. In May 2025, Royalty Pharma acquired its external investment manager RP Management in a $1.1 billion deal. Legorreta owned 100% of RPM until 2024, when he gave just under half his stake to employees

Wealth Growth

Net Worth Growth Over Time

Tracking Pablo Legorreta's net worth journey over the years, highlighting key growth phases and financial milestones.

Worth Trend Net Worth Growth
Period Change Worth Movement
Current Net Worth: $5.2B (May 4, 2026)

© Iconic Billionaires